Abeona Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$6.86(as of Jul 29, 1:16 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Abeona Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$6.86
Ticker SymbolABEO
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees136
CountyUSA
Market Cap$334.1M
EBIDTA-67.6M
10-Day Moving Average6.52
P/E Ratio-7.46
20-Day Moving Average6.16
Forward P/E Ratio0.00
50-Day Moving Average6.17
Earnings per Share-0.63
200-Day Moving Average5.79
Profit Margin-Infinity%
RSI60.76
Shares Outstanding51.2M
ATR0.30
52-Week High7.32
Volume586,484
52-Week Low3.93
Most Recent Support Level6.36
Book Value41.4M
Most Recent Resistance Level6.84
P/B Ratio7.96
Upper Keltner6.83
P/S RatioInfinity
Lower Keltner5.49
Debt-to-Equity Ratio6.83
Next Earnings Date08/18/2025
Cash Surplus-2.0M
Next Ex-Dividend DateUnknown

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

Abeona Therapeutics Inc In Our Stock Scanner

As of Jul 29, 2025
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.